ANEUVO(ANEUVO)
ANEUVO is revolutionizing bioelectronic medicine through innovative neuromodulation therapies that restore independence, improve quality of life, and promote health equity for those with chronic conditions. Our flagship ExaStim® system delivers non-invasive, non-surgical treatment for conditions poorly managed by conventional methods. With CE Certification, we are launching in the EU, focusing first on spinal cord injury (SCI). Our approach is supported by patented technology, strong Level I clinical evidence, and a clear regulatory path. Backed by decades of SCI research and a distinctive revenue model, ANEUVO is uniquely positioned for rapid growth and presents a compelling investment in next-generation healthcare solutions.